Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1954
HER2amp
Basal A
Epirubicin
TOP2
TOP
7837.017
uM
0.24556
0.50357
-0.9883 -0.8902 1.4238 0.8549
0.9929
1.4255
HCC1954
HER2amp
Basal A
Erlotinib
EGFR
ErbB
7454.092
uM
1.06490
35.62910
-0.0632 -1.0000 0.3130 0.3444
0.8804
1.2402
HCC1954
HER2amp
Basal A
Erlotinib
EGFR
ErbB
7455.092
uM
13.18290
51.93090
0.1595 -1.0000 0.8013 0.0884
0.9620
1.6605
HCC1954
HER2amp
Basal A
Erlotinib
EGFR
ErbB
7456.091
uM
2.67810
2.49550
0.1750 0.0191 0.5509 0.2778
0.9854
1.7629
HCC1954
HER2amp
Basal A
Erlotinib
EGFR
ErbB
7457.09
uM
7.4150
31.9160
0.2264 -0.3592 0.3709 0.2375
0.9906
1.7392
HCC1954
HER2amp
Basal A
Etoposide
TOP2
TOP
7457.074
uM
0.87235
5.0640
-0.7665 -0.9731 0.6144 0.6928
0.9844
1.6514
HCC1954
HER2amp
Basal A
Etoposide
TOP2
TOP
7456.074
uM
1.5450
5.74210
-0.6725 -0.7985 0.7270 0.5693
0.9867
1.9647
HCC1954
HER2amp
Basal A
Everolimus
MTOR
MTOR
11055.156
uM
0.62409
9.09660
-0.8901 -1.0000 0.4100 0.4574
0.7682
1.5301
HCC1954
HER2amp
Basal A
Fascaplysin
CDK4
CDK
7457.084
uM
0.27072
0.36801
-0.8722 -0.8629 3.2661 0.6637
0.9979
1.8520
HCC1954
HER2amp
Basal A
Fascaplysin
CDK4
CDK
7456.084
uM
0.31254
0.47190
-0.8694 -0.8430 2.3979 0.6118
0.9984
1.9822
HCC1954
HER2amp
Basal A
FR180204
ERK1/2
MAPK
11055.149
uM
inf
1000.00000
0.8007 0.3725 0.2559 0.0652
0.8798
1.6723
HCC1954
HER2amp
Basal A
FTase Inhibitor I
Ftase
MAPK
11055.154
uM
inf
inf
0.9813 0.9813 0.0000 0.0080
-0.0117
1.7768
HCC1954
HER2amp
Basal A
Gefitinib
EGFR
ErbB
9386.132
uM
inf
inf
0.7520 0.7520 0.0000 0.1148
0.0425
1.4083
HCC1954
HER2amp
Basal A
Gefitinib
EGFR
ErbB
7837.016
uM
0.63768
9.62580
-0.3488 -1.0000 0.4047 0.4170
0.8709
1.8067
HCC1954
HER2amp
Basal A
Gefitinib
EGFR
ErbB
7839.016
uM
2.34040
8.15740
-0.6232 -1.0000 0.8799 0.2539
0.9792
1.5556
HCC1954
HER2amp
Basal A
Gefitinib
EGFR
ErbB
7836.016
uM
3.16010
11.63650
-0.4521 -1.0000 0.8428 0.2443
0.9855
1.5669
HCC1954
HER2amp
Basal A
Geldanamycin
HSP90
HSP90
9386.012
uM
0.00916
0.01053
-0.3816 -0.2949 3.3202 0.9016
0.9952
1.4141
HCC1954
HER2amp
Basal A
Gemcitabine
DNA replication
DNA replication
9386.011
uM
inf
0.01184
0.6016 0.6206 0.8409 0.2743
0.9746
1.5229
HCC1954
HER2amp
Basal A
Glycyl-H-1152
ROCK2
11055.15
uM
inf
inf
0.8945 0.8945 0.0000 -0.0190
0.5352
1.6412
HCC1954
HER2amp
Basal A
GSK1070916
AURK
AURK
9386.001
uM
5.04710
9.51350
-0.8649 -1.0000 1.7331 0.2427
0.9794
1.3243
HCC1954
HER2amp
Basal A
GSK1070916
AURK
AURK
7839.001
uM
3.91050
8.65220
-0.8109 -1.0000 1.3834 0.2338
0.9835
1.8919
HCC1954
HER2amp
Basal A
GSK1070916
AURK
AURK
7837.001
uM
3.3970
7.34280
-0.8678 -1.0000 1.4253 0.2376
0.9916
1.5358
HCC1954
HER2amp
Basal A
GSK1838705A
IGF1R
RTK
7454.092
uM
inf
inf
0.7036 0.7036 0.0000 0.2005
0.0931
1.2402
HCC1954
HER2amp
Basal A
GSK1838705A
IGF1R
RTK
7457.09
uM
inf
inf
0.9111 0.9111 0.0000 0.0435
0.5105
1.7392
HCC1954
HER2amp
Basal A
GSK1838705A
IGF1R
RTK
7456.098
uM
inf
2.98790
0.7969 0.8533 4.9991 0.0495
0.6286
1.7388